Nevrargenics Ltd.

Discovers and develops novel medicines for the treatment of neurodegenerative diseases (ALS, frontotemporal dementia, Alzheimer’s, Parkinson’s, multiple sclerosis) and other conditions including liver and eye diseases, targeting patients in need of new therapies.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading